Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
4-(4-Ethylpiperazin-1-yl)aniline → 8-(2-Chloro-5-methoxy-phenyl)-quinoxaline-5-carboxylic acid [4-(4-ethyl-piperazin-1-yl)-phenyl]-amide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 4-(4-Ethylpiperazin-1-yl)aniline | HCID 936738 | — |
| 반응물 | 8-(2-Chloro-5-methoxy-phenyl)-quinoxaline-5-carboxylic acid [3-(4-ethyl-piperazin-1-yl)-phenyl]-amide | HCID 44515980 | — |
| 생성물 | 8-(2-Chloro-5-methoxy-phenyl)-quinoxaline-5-carboxylic acid [4-(4-ethyl-piperazin-1-yl)-phenyl]-amide | HCID 44516280 | — |
반응 단계
The title compound was prepared in analogy to the procedure described in Step 14.1 but using 4-(4-ethylpiperazin-1-yl)-aniline (Step 1.9) and 8-(2-chloro-5-methoxy-phenyl)-quinoxaline-5-carboxylic acid (Example 63). Title compound: ESI-MS: 502.1 [M]+; tR=3.50 min (System 3).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08273882B2 |
| 출처 데이터셋 | uspto-grants-2012_09 |
| ORD ID | ord-602ef9cacc554b309bf3a7f410112e25 |
| 출처 메모 | uspto-grants-2012_09 |